New York Times on the NHTSA
On Monday Sept. 14, the New York Times began running a series of articles outlining the systematic failure of federal regulators to identify dangerous defects
Read MoreMedtronic Recall
The U.S. Food and Drug Administration recently announced that it had classified Medtronic’s recall of its MiniMed Paradigm Infusion pumps as a Class II recall.
Read MoreDePuy ASR Total Hip Replacement Settlement Update
DePuy Settlement is Moving Forward DePuy Orthopaedics, a medical device manufacturer unit owned by Johnson & Johnson, announced a few days prior to a June
Read MoreASR Hip Implant Settlement Update
ASR Hip Implant Settlement Update (May 15th, 2014): It appears that over 7,200 ASR patients have enrolled in the U.S. ASR Hip Implant Settlement Program.
Read More
DePuy ASR Hip Implant Litigation Update
Rather than do what’s right and settle the lawsuits filed against the company in relation to its DePuy Hip Implant Products. Johnson and Johnson has
Read More
Zimmer Holdings’ Purchase of Biomet May Speed Up Settlement Negotiations
On April 24, 2014, Zimmer Holdings announced that it will purchase Biomet, Inc., for $13.35 billion. The sale is expected to go through by the first quarter of
Read More